Overview
Flumatinib has been used in trials studying the treatment of Myelogenous Leukemia, Chronic.
Indication
用于治疗费城染色体阳性的慢性髓性白血病（Ph+CML）慢性期成人患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/06/27 | Phase 2 | Completed | The First Affiliated Hospital of Soochow University | ||
2022/05/10 | Phase 4 | Not yet recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | ||
2022/04/29 | Phase 4 | Recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | ||
2021/10/08 | Phase 4 | Terminated | |||
2021/06/21 | Phase 4 | UNKNOWN | Shenzhen Second People's Hospital | ||
2021/02/05 | N/A | Recruiting | The First Affiliated Hospital of Soochow University | ||
2020/12/23 | N/A | Recruiting | Wuhan Union Hospital, China | ||
2020/12/21 | Phase 4 | UNKNOWN | Shenzhen Second People's Hospital | ||
2020/05/05 | Phase 3 | UNKNOWN | Zhongda Hospital | ||
2015/07/30 | Phase 2 | UNKNOWN | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.